Overview
7 featuresIn the Medical & telehealth space, EGK AIPharmaCalc takes a focused approach. It focuses on simplifying and automating pharmacokinetics calculations and clinical interpretation for pharmacy professionals. EGK AIPharmaCalc is a consumer product aimed at pharmacy students and pharmaceutical scientists. Pricing is paid, from $6.99. It runs on iOS.
It is developed by Isaac Eng Gian Khor (United States), and it first shipped in 2026. Key capabilities include PK simulation engine, multiple compartment models, and route simulation.
- ✓PK simulation engine
- ✓Multiple compartment models
- ✓Route simulation
- ✓Real-time parameter calculation
- ✓AI interpretation
- ✓Therapeutic window analysis
- ✓Dose adjustment recommendations
Tagspharmacokineticsai-interpretationpk-simulationdose-adjustmentclinical-analysis
AI capabilitiesStructuredText
Inference: Cloud API
Built with & integrations
Trust & compliance
Verified signals✓HTTPS✓Store-verified publisher
Indexing history
1What PulseGate has recorded for this listing
Indexed27 Jun · 07:31 UTC
Listing verified against its public source
Frequently asked questions about EGK AIPharmaCalc
- What is EGK AIPharmaCalc?
- EGK AIPharmaCalc focuses on simplifying and automating pharmacokinetics calculations and clinical interpretation for pharmacy professionals. It is catalogued under Medical & telehealth on PulseGate.
- Who is EGK AIPharmaCalc for?
- EGK AIPharmaCalc is a consumer product built for pharmacy students and pharmaceutical scientists.
- How much does EGK AIPharmaCalc cost?
- Paid plans start at $6.99.
- What platforms does EGK AIPharmaCalc run on?
- EGK AIPharmaCalc runs on iOS.
- Is EGK AIPharmaCalc still maintained?
- Unverified. EGK AIPharmaCalc has not been re-checked since it entered the index, so there is no finding either way — and only a positive finding would say otherwise.
- Who makes EGK AIPharmaCalc?
- EGK AIPharmaCalc is developed by Isaac Eng Gian Khor, based in the United States.
- How long has EGK AIPharmaCalc been around?
- EGK AIPharmaCalc first shipped in 2026.